Venture capital investment manager, Deepbridge Capital has deployed a record £31.5 million into early-stage technology and life sciences companies during the 2021/22 tax year, up from £29.4 million in 2020/21.

Providing private investors with access to portfolios of innovative and growth focused companies, Deepbridge manages the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS funds which offer private investors significant tax reliefs via the UK Government’s Enterprise Investment Scheme (EIS).

Some 52 companies received funding via Deepbridge in 2021/22, based across England, Scotland, Wales and Northern Ireland.  Companies to receive funding included the likes of rocket propulsion pioneers Smallspark Space Systems, vital signs monitoring tech developers Metix, event management platform Headbox, novel chemical technology developer Liverpool ChiroChem and sustainable algae manufacturing tech company AlgaeCytes.

Click here to red the full article 



020 7071 3945


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.